| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Alcohol-related harm during the COVID-19 pandemic
|
The Lancet Gastroenterology & Hepatology,
|
|
|
6 |
7 |
p. 511
|
artikel
|
| 2 |
Anal cancer screening in low-income and middle-income countries
|
Blair, Kevin J
|
|
|
6 |
7 |
p. 526
|
artikel
|
| 3 |
Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
|
Qin, Shukui
|
|
|
6 |
7 |
p. 559-568
|
artikel
|
| 4 |
Breaking the therapeutic ceiling in drug development in ulcerative colitis
|
Alsoud, Dahham
|
|
|
6 |
7 |
p. 589-595
|
artikel
|
| 5 |
COVID-19: Colorectal cancer endoscopic surveillance in IBD
|
Din, Shahida
|
|
|
6 |
7 |
p. 526
|
artikel
|
| 6 |
Cuts to UK official development assistance budget jeopardise global viral hepatitis elimination goals
|
Lemoine, Maud
|
|
|
6 |
7 |
p. 527-528
|
artikel
|
| 7 |
Defining difficult-to-treat inflammatory bowel disease: why and how
|
Danese, Silvio
|
|
|
6 |
7 |
p. 520-522
|
artikel
|
| 8 |
Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study
|
Hajarizadeh, Behzad
|
|
|
6 |
7 |
p. 533-546
|
artikel
|
| 9 |
Food-additive emulsifiers: the worst thing since sliced bread?
|
Cox, Selina R
|
|
|
6 |
7 |
p. 532
|
artikel
|
| 10 |
Ingestion of high-power magnets: cause for concern
|
The Lancet Gastroenterology & Hepatology,
|
|
|
6 |
7 |
p. 511
|
artikel
|
| 11 |
Long-term safety of laparoscopic rectal cancer resection
|
Tanis, Pieter J
|
|
|
6 |
7 |
p. 516-518
|
artikel
|
| 12 |
Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach
|
Targher, Giovanni
|
|
|
6 |
7 |
p. 578-588
|
artikel
|
| 13 |
Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): 10-year follow-up of an open-label, non-inferiority, randomised controlled trial
|
Park, Ji Won
|
|
|
6 |
7 |
p. 569-577
|
artikel
|
| 14 |
Research in Brief
|
Baker, Holly
|
|
|
6 |
7 |
p. 531
|
artikel
|
| 15 |
SARS-CoV-2 vaccination for patients with inflammatory bowel disease
|
Garrido, Hannah M Garcia
|
|
|
6 |
7 |
p. 523
|
artikel
|
| 16 |
SARS-CoV-2 vaccination for patients with inflammatory bowel disease – Authors' reply
|
Alexander, James L
|
|
|
6 |
7 |
p. 523-524
|
artikel
|
| 17 |
SARS-CoV-2 vaccination in immunosuppressed patients with inflammatory bowel disease: should our approach change?
|
Alexander, James L
|
|
|
6 |
7 |
p. 528-529
|
artikel
|
| 18 |
Stent insertion for incurable oesophageal carcinoma: what is the optimal treatment?
|
Tian, Dong
|
|
|
6 |
7 |
p. 524-525
|
artikel
|
| 19 |
Stent insertion for incurable oesophageal carcinoma: what is the optimal treatment? – Authors' reply
|
Byrne, Anthony
|
|
|
6 |
7 |
p. 525
|
artikel
|
| 20 |
Therapeutic targeting of VEGFR2 in HBV-associated hepatocellular carcinoma
|
Pinato, David J
|
|
|
6 |
7 |
p. 515-516
|
artikel
|
| 21 |
Towards meaningful change: the future of gastroenterology belongs to women, diversity, equity, and inclusion
|
Matharoo, Manmeet K
|
|
|
6 |
7 |
p. 518-520
|
artikel
|
| 22 |
Treatment-as-prevention in prison settings: a growing evidence base for HCV elimination efforts
|
Tavoschi, Lara
|
|
|
6 |
7 |
p. 512-513
|
artikel
|
| 23 |
Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy
|
Black, Mairead
|
|
|
6 |
7 |
p. 513-515
|
artikel
|
| 24 |
Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a systematic review and individual participant data meta-analysis
|
Ovadia, Caroline
|
|
|
6 |
7 |
p. 547-558
|
artikel
|
| 25 |
USPSTF: colorectal cancer screening in the US from 45 years
|
Burki, Talha K
|
|
|
6 |
7 |
p. 530
|
artikel
|
| 26 |
Whitish elevated lesion in the oesophagus: verrucous carcinoma
|
Katano, Takahito
|
|
|
6 |
7 |
p. 596
|
artikel
|
Tijdschrift beschrijving